Back Page - Pharmaceutical Executive


Back Page
A pharma miscellany.

Brand Building—Not!

August 1, 2012

As a drug company promoting a drug free Olympiad, GSK wins our gold hands down for finally putting the industry's best face forward on the last frontier of advertising—the TV sets of Europe.

John Lechleiter on PhRMA and Innovation

July 1, 2012

Eli Lilly CEO John Lechleiter on his agenda as incoming chairman of PhRMA, US healthcare reform, the euro crisis, and the small problem, of innovation.

Disruption in the C-Suite

June 1, 2012

Clayton Christensen, author of "The Innovator's Dilemma", offers to collaborate with pharma CEOs on solutions to the strategic impasse around flagging drug productivity.

Comparing Apples to Broccoli

May 1, 2012

In late March, the Supreme Court debated the merits—or lack thereof—of the Obama Administration's Patient Protection and Affordable Care Act. Can you match the analogy with the Justice?

Scotland, Independence, and Pharma

April 1, 2012

What does a Scottish vote for independence mean for Big Pharma investment and healthcare funding and delivery in the UK?

Betting on Bigger Data

March 1, 2012

In the rush to collect as much patient data as possible, are we sacrificing quality for quantity? Ben Comer reports.

FDA Social Media Guidelines: Irresponsible?

February 1, 2012

After two years of waiting, FDA issued the first in a series of planned guidelines on social media at the end of last year. We look at some of the experts' reactions.

Top Medical Innovations 2012

January 1, 2012

A selection of the recent breakthrough technologies showcased at the Cleveland Clinic's Medical Innovations Summit.

Artists & Ad Men

December 1, 2011

Some of the most creative and influential graphic designers and illustrators did time in pharma marketing.


Click here